Agenus to Present Botensilimab Data at a Plenary Session of the Society for Immunotherapy of Cancer (SITC) 37th Annual MeetingGlobeNewsWire • 10/05/22
Here is What to Know Beyond Why Agenus Inc. (AGEN) is a Trending StockZacks Investment Research • 09/30/22
Agenus Initiates Botensilimab Phase 2 ACTIVATE Trials in Advanced MSS Colorectal Cancer and Advanced MelanomaGlobeNewsWire • 09/12/22
Agenus Inc. (AGEN) CEO Garo Armen on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/09/22
Agenus Announces First Patient Dosed in Phase 1 Study of AGEN1571 (anti-ILT2) in Advanced Solid TumorsGlobeNewsWire • 08/01/22
Agenus Touts 'Unprecedented Activity' For Botensilimab/Balstilimab Combo In Colorectal CancerBenzinga • 06/29/22
Agenus Shows Unprecedented Activity for Botensilimab/Balstilimab Combination in Microsatellite Stable Colorectal Cancer at ESMO World GI CongressGlobeNewsWire • 06/29/22
Agenus to Host Investor Webcast to Review Late-Breaking Botensilimab and Balstilimab Data Presented at ESMO World GI CongressGlobeNewsWire • 06/21/22
GSK's RSV vaccine candidate for older adults, containing Agenus' QS-21 STIMULON™ as part of GSK's AS01 adjuvant, reports positive pivotal data supporting initiation of global regulatory submissionsGlobeNewsWire • 06/10/22